APPLICATION
ANDA090790
TYPE
ANDA
ORIGINAL APPROVAL
2010-10-06
LATEST ACTION
2016-06-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
LOSARTAN POTASSIUMDiscontinued
LOSARTAN POTASSIUM 50MG · TABLET · ORAL
LOSARTAN POTASSIUMDiscontinued
LOSARTAN POTASSIUM 100MG · TABLET · ORAL
LOSARTAN POTASSIUMDiscontinued
LOSARTAN POTASSIUM 25MG · TABLET · ORAL
Approval history
2016-06-10Labeling · Supplement 9 · standardAP
2015-03-09Labeling · Supplement 7 · standardAP
2015-03-09Labeling · Supplement 8 · standardAP
2014-11-05Labeling · Supplement 5 · standardAP
2014-11-05Labeling · Supplement 6 · standardAP
2012-12-20Labeling · Supplement 4 · standardAP
2011-04-19Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.